Investing Ideas
/
Belgian Pharmaceuticals & Biotech Top Stock Picks from Analysts

Belgian Pharmaceuticals & Biotech Top Stock Picks from Analysts

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which are more than 50% undervalued based on analyst price target.

1 companies

Hyloris Pharmaceuticals

Market Cap: €128.8m

Operates as a specialty pharmaceutical company in Belgium, the United States, Europe, the Middle East, Africa, and Asia-Pacific.

HYL

€4.79

4.1%

-23.5%